บุคลากรสายวิชาการ

รศ.ดร.ภญ. อุษา ฉายเกล็ดแก้ว รศ.ดร.ภญ. อุษา ฉายเกล็ดแก้ว usa.chi@mahidol.ac.th usa.chi@mahidol.ac.th อาจารย์ประจำภาควิชาเภสัชกรรม , รองคณบดีฝ่ายวิเทศสัมพันธ์และประชาสัมพันธ์

2021

1. A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy

   Turongkaravee S, Jittikoon J*, Lukkunaprasit T, Sangroongruangsri S, Chaikledkaew U, Thakkinstian A. Pharmacogenomics J 2021; 21(3): 296-307.
   
   

2. A systematic review of demand-side methods of estimating the societal monetary value of health gain

   Gloria MAJ, Thavorncharoensap M*, Chaikledkaew U, Youngkong S, Thakkinstian A, Culyer AJ. Value in Health 2021; 24(10): 1423-1434.
   
   

3. Cartilage oligomeric matrix protein as a marker of progressive liver fibrosis in biliary atresia

   Udomsinprasert W*, Angkathunyakul N, Jittikoon J, Chaikledkaew U, Vejchapipat P, Poovorawan Y, Honsawek S. Scientific Reports 2021; 11(1): 16695.
   
   

4. Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases

   Udomsinprasert W*, Sobhonslidsuk A, Jittikoon J, Honsawek S, Chaikledkaew U. Expert Opinion on Therapeutic Targets 2021; 25(9): 799-813.
   
   

5. Circulating levels of interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with meta-analysis

   Udomsinprasert W*, Jittikoon J, Sangroongruangsri S, Chaikledkaew U. Journal of clinical immunology 2021; 41(1): 11-22.
   
   

6. Cost-effectiveness analysis of diagnostic tests for para-aortic lymph node detection in locally advanced cervical cancer

   Katanyoo K, Chaikledkaew U*, Thavorncharoensap M, Riewpaiboon A. Clinicoecon Outcomes Res 2021; 13: 943-955.
   
   

7. Cost-utility analysis of dapagliflozin compared to sulfonylureas for type 2 diabetes as second-line treatment in indian healthcare payer’s perspective

   Bagepally BS, Chaikledkaew U*, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A. ClinicoEconomics and Outcomes Research 2021; 13: 897-907.
   
   

8. Cost-utility analysis of drug treatments in patients with polypoidal choroidal vasculopathy in Thailand

   Sangroongruangsri S, Chaikledkaew U*, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P. ClinicoEconomics and Outcomes Research 2021; 13: 917-926.
   
   

9. Cost-utility analysis of vasoconstrictors plus albumin in the treatment of thai patients with type 1 hepatorenal syndrome

   Sangroongruangsri S, Kittrongsiri K, Charatcharoenwitthaya P, Sobhonslidsuk A, Chaikledkaew U*. ClinicoEconomics and Outcomes Research 2021; 13: 703-715.
   
   

10. CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients

    Chanhom N, Wattanapokayakit S, Satproedprai N, Suvichapanich S, Mahasirimongkol S, Chaikledkaew U, Udomsinprasert W, Mushiroda T, Jittikoon J*. Heliyon 2021; 7(4): e06852.
    
    

11. Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment

    Genuino AJ, Gloria MAJ, Chaikledkaew U*, Reungwetwattana T, Thakkinstian A. Expert Review of Pharmacoeconomics and Outcomes Research 2021; 21(5): 1001-1010.
    
    

12. Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam

    Toi PL, Wu O, Thavorncharoensap M, Srinonprasert V, Anothaisintawee T, Thakkinstian A, Phuong NK, Chaikledkaew U*. PLoS One 2021; 16(12): e0261231.
    
    

13. Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury

    Udomsinprasert W*, Sakuntasri W, Jittikoon J, Chaikledkaew U, Honsawek S, Chantratita W, Wattanapokayakit S, Mahasirimongkol S. Emerging Microbes and Infections 2021; 10(1): 1862-1872.
    
    

14. Incremental net monetary benefit of bariatric surgery: Systematic review and meta-analysis of cost-effectiveness evidences

    Noparatayaporn P, Thavorncharoensap M*, Chaikledkaew U, Bagepally BS, Thakkinstian A. Obesity Surgery 2021; 31(7): 3279-3290.
    
    

15. Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

    Turongkaravee S, Jittikoon J, Rochanathimoke O, Boyd K, Wu O, Chaikledkaew U*. BMC Health Services Research 2021; 21(1): 1042.
    
    

16. The Cost of locally advanced cervical cancer in Thailand: An empirical study for economic analysis

    Katanyoo K, Riewpaiboon A*, Chaikledkaew U, Thavorncharoensap M. Asian Pacific Journal of Cancer Prevention 2021; 22(10): 3171-3179.
    
    

2020

1. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis

   Udomsinprasert W*, Jittikoon J, Sukkho S, Pojarassangkul N, Sangroongruangsri S, Chaikledkaew U. Journal of infection 2020; 81(4): 585-599.
   
   

2. Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis

   Karnjanapiboonwong A, Anothaisintawee T*, Chaikledkaew U, Dejthevaporn C, Attia J, Thakkinstian A. BMC Cardiovascular Disorders 2020; 20(1):491.
   
   

3. Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines

   Briones JR, Talungchit P, Thavorncharoensap M, Chaikledkaew U*. BMC health services research 2020; 20(1): 975.
   
   

4. Economic impact of medical genetic testing on clinical applications in Thailand

   Jittikoon J, Sangroongruangsri S, Thavorncharoensap M, Chitpim N, Chaikledkaew U*. PLoS one 2020; 15(12): e0243934.
   
   

5. Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: Systematic review and meta-analysis of economic evaluation studies

   Bagepally BS, Chaikledkaew U*, Gurav YK, Anothaisintawee T, Youngkong S, Chaiyakunapruk N, McEvoy M, Attia J, Thakkinstian A. BMJ open diabetes res care 2020; 8(1): e001020.
   
   

6. GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury

   Chanhom N, Udomsinprasert W, Chaikledkaew U, Mahasirimongkol S, Wattanapokayakit S, Jittikoon J*. Biomedical reports 2020; 12(4): 153-162.
   
   

7. Preventive role of diet interventions and dietary factors in type 2 diabetes mellitus: An umbrella review

   Toi PL, Anothaisintawee T*, Chaikledkaew U, Briones JR, Reutrakul S, Thakkinstian A. Nutrients 2020; 12(9): 2722: 1-17.
   
   

8. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand

   Sukkha S, Rattanavipanon W, Chamroenwit B, Sanganurak M, Nathisuwan S, Chaikledkaew U, Kongwatcharapong J*. International journal of clinical pharmacy 2020; 42(2): 610-616.
   
   

9. Survival analysis of colorectal cancer patients in a Thai hospital-based cancer registry

   Kittrongsiri K, Wanichsuwan W, Prechawittayakul P, Sangroongruangsri S, Cairns J, Chaikledkaew U*. Expert Review of gastroenterology & hepatology 2020; 14(4): 291-300.
   
   

2019

1. A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand

   Kumluang S, Ingsrisawang L*, Sangroongruangsri S, Chaikledkaew U, Ratanapakorn T, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Thoongsuwan S, Hanutsaha P, Kulvichit K, Ratanapojnard T, Wongsawad W, Leelahavarong P, Teerawattananon Y. BMC Ophthalmology 2019; 19(1); 82.
   
   

2. Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis

   Genuino AJ, Chaikledkaew U*, The DO, Reungwetwattana T, Thakkinstian A. Expert Review of Clinical Pharmacology 2019; 12(8); 815-824.
   
   

3. Burden of Diseases among Nursing Staff in a Tertiary Hospital in Thailand

   Lertpitakpong C,Sriratanaban J, Chaikledkaew U, Hanvoravongchai P. PACIFIC RIM INTERNATIONAL JOURNAL OF NURSING RESEARCH 2019;23(2):180-193
   
   

4. Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review

   Anothaisintawee T, Julienne Genuino A, Thavorncharoensap M, Youngkong S, Rattanavipapong W, Meeyai A, Chaikledkaew U*. Vaccine 2019; 37: A146-A153.
   
   

5. Publication Preview Source Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives

   Chumnumwat S, Lu Z, H, Sukasem C, Winther M, D, Capule F, R, Abdul Hamid A, A, Bhandari B, Chaikledkaew U, Chanhom N, Chantarangsu S, Charoenyingwattana A, Hang T, T, Hlaing T, M, Htun K, S, Jittikoon J, Le L, Mahasirimongkol S, Mohamed Noor D, A, Sh Public Health Genomics
   
   

6. Real-world safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: A prospective observational study

   Sangroongruangsri S, Chaikledkaew U*, Kumluang S, Wu O, Geue C  , Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn Clinical Drug Investigation 2019; 39(1): 115-115.
   
   

7. Revisit roles of HTA on drug policy in universal health coverage in Thailand: Where are we? and what is next?

   Tanvejsilp P, Taychakhoonavudh S, Chaikledkaew U, Chaiyakunapruk N, Ngorsuraches S*. Value in Health Regional Issues 2019; 18: 78-82.
   
   

8. Systematic review and meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries

   Haider S, Chaikledkaew U*, Thavorncharoensap M, Youngkong S, Islam MA, Thakkinstian A . Open Forum Infectious Diseases 2019; 6(4); ofz117.
   
   

9. The impact of transmission dynamics of rabies control: Systematic review

   Rattanavipapong W, Thavorncharoensap M, Youngkong S, Genuino AJ, Anothaisintawee T, Chaikledkaew U, Meeyai A*. Vaccine 2019; A154-A165.
   
   

10. Treatment cost and costing model of obstetric complications at a hospital in Myanmar

    Thi Win Shwe A, Riewpaiboon A*, Chaikledkaew U, Youngkong S. PLoS ONE 2019;14(3):e0213141
    
    

2018

1. Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis

   Sangroongruangsri S., Ratanapakorn T., Wu O., Anothaisintawee T., Chaikledkaew U. Expert Review of Clinical Pharmacology 2018; 11(9): 903-916.
   
   

2. Development of Relative Value Units for Unit Cost analysis of Medical Services in Vietnam

   Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): s19-s26
   
   

3. Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions

   Nam V.X., Nhung N.V., Hoa N.B., Thuy H.T.T., Phuong N.T.M., Anh N.T., Ngoc Anh L.T., Trung V.Q., Ha T.V., Meeyai A., Thavorncharoensap M., Chaikledkaew U. International Journal of Tuberculosis and Lung Disease 2018; 22(8): 912-917.
   
   

4. Economic costs of alcohol use in Sri Lanka

   Ranaweera S, Amarasinghe H, Chandraratne N*, Thavorncharoensap M., Ranasinghe T, Karunaratna S, Kumara D, Santatiwongchai B, Chaikledkaew U, Abeykoon P, De Silva A. PLoS ONE 2018; 13(6): Art.no.e0198640
   
   

5. Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand

   Siritho S., Thavorncharoensap M., Chanatittarat C., Pasogpakdee P., Apiwattanakul M., Prayoonwiwat N., Chankrachang S., Riewpaiboon A., Chaikledkaew U. Multiple Sclerosis and Related Disorders 2018; 24: 151-156.
   
   

6. Hospital cost analysis in developing countries: A methodological comparison in Vietnam

   Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): S8-S18.
   
   

7. Influenza vaccination in acute coronary syndromes patients in Thailand: The cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia

   Sribhutorn A., Phrommintikul A., Wongcharoen W., Chaikledkaew U., Eakanunkul S., Sukonthasarn A. Journal of Geriatric Cardiology 2018; 15(6): 413-421.
   
   

8. Modelling the health economic impact of influenza vaccination strategies for high-risk children in Vietnam

   Vo T.Q., Chaikledkaew U., Van Hoang M., Riewpaiboon A. Journal of Clinical and Diagnostic Research 2018; 12(6): LC26-LC32.
   
   

9. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: A genotype-based meta-analysis

   Suvichapanich S, Fukunaga K, Zahroh H, Mushiroda T, Mahasirimongkol S*, Toyo-Oka L, Chaikledkaew U, Jittikoon J, Yuliwulandari R, Yanai H, Wattanapokayakit S, Tokunaga K. Pharmacogenetics and Genomics 2018; 28(7): 167-176
   
   

10. Prognostic indicators for heart failure hospitalization in acute coronary syndrome patients: An observational study under the influenza vaccination trial

    Sribhutorn A., Phrommintikul A., Wongcharoen W., Chaikledkaew U., Eakanunkul S., Patumanond J., Sukonthasarn A. Journal of the Medical Association of Thailand 2018; 101(8): 1043-1049
    
    

11. Real-World safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: A prospective observational study

    Sangroongruangsri S, Chaikledkaew U*, Kumluang S, Wu O, Geue C, Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Singalavanija A, Hanutsaha P Clinical Drug Investigation 2018; 38(9): 853-865
    
    

2017

1. Cost of Acute Care For Ischemic Stroke in Thailand

   Sribundit N*, Riewpaiboon A, Chaikledkaew U, Stewart JF, Tantirittisak T, Hanchaipiboolkul S. Southeast Asian Journal of Tropical Medicine and Public Health 2017; 48(3): 628-640.
   
   

2. Economic burden of influenza at a tertiary hospital in Vietnam

   Vo TQ, Chaikledkaew U, Hoang MV, Riewpaiboon A.* Asian Pacific Journal of Tropical Disease 2017; 7(3): 144-150
   
   

3. Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam

   Quang Vo T, Chaikledkaew U, van Hoang M, Riewpaiboon A*. ClinicoEconomics and Outcomes Research 2017; 9: 423-432
   
   

2016

1. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations

   Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y.f, Mcleod H.L.f, Chantratita W*. Journal of Human Genetics. 2016; 61(2): 119-127.
   
   

2. Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand

   Thongsri W, Bussabawalai T, Leelahavarong P, Wanitkun S, Durongpisitkul K, Chaikledkaew U*, Teerawattananon Y. Expert Review of Pharmacoeconomics and Outcomes Research 2016; 16(4): 525-536.
   
   

3. Healthcare costing studies in developing countries: A systematic review in Vietnam

   Vo TQ, Chaikledkaew U, Van Hoang M, Riewpaiboon A*. International Journal of Pharmaceutical Sciences Review and Research 2016; 39(2): 295-299.
   
   

4. Nationwide survey of nutritional management in an Asian upper-middle income developing country government hospitals: Combination of quantitative survey and focus group discussion

   Chittawatanarat K, Tosanguan K, Chaikledkaew U, Tejavanija S, Teerawattananon Y. Clinical Nutrition ESPEN 2016; 14: 24-30
   
   

5. The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial

   Sribhutorn A, Phrommintikul A*, Wongcharoen W, Chaikledkaew U, Eakanunkul S, Sukonthasarn A. Cardiology Research and Practice 2016; 2016:4097471.
   
   

2015

1. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.

   Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W*. Journal of Human Genetics 2015; 1-9
   
   

2. Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand

   Lerdkiattikorn P, Chaikledkaew U, Lausoontornsiri W, Chindavijak S, Khuhaprema, T, Tantai N, Teerawattananon Y. Expert Review of Pharmacoeconomics and Outcomes Research 2015; 15(4): 687-700
   
   

3. Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand

   Thongsri W, Bussabawalai T, Leelahavarong P, Wanitkun S, Durongpisitkul K, Chaikledkaew U*, Teerawattananon Y. Expert Review of Pharmacoeconomics and Outcomes Research 2015; 1-12
   
   

4. Prevalence of Idiopathic Inflammatory Demyelinating Central Nervous System Disorder in Thailand

   Prayoonwiwat N, Apiwattanakul M, Pasogpakdee P, Siritho S, Chanatittarat C, Chaikledkaew U. Multiple sclerosis journal. 2015; 21(6): 824-824.
   
   

5. The Quality of Life in Thai Patients with Neuromyelitis Optica Spectrum Disorders

   Siritho S, Pasogpakdee P, Apiwattanakul M, Prayoonwiwat N, Chankrachang S, Chanatittarat C, Chaikledkaew U. Multiple sclerosis journal 2015; 21(6): 825-826
   
   

2014

1. A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand

   Tantai N, Chaikledkaew U*, Tanwandee T, Werayingyong P, Teerawattananon Y. BMC Health Services Research 2014; 14(1)
   
   

2. Adverse Drug Event of Hospitalized Patients from Multi-Hospitals in Thailand

   Tragulpiankit P, Yeesoonpan N, Ninsananda T, Chindavijak B, Chulavatnatol S, Chaikledkaew U, Uaviseswong T. Pharmacoepidemiology and drug safety 2014; 23: 289-289
   
   

3. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in thai chronic hepatitis B patients

   Sangmala P, Chaikledkaew U*, Tanwandee T, Pongchareonsuk P. Asian Pacific Journal of Cancer Prevention 2014; 15(20): 8993-9004
   
   

4. Economic Evaluation of Colorectal Cancer Screening: A Systematic Review

   Kittrongsiri K, Chaikledkaew U*. Mahidol University Journal of Pharmaceutical Sciences 2014; 41 (2), 31-38
   
   

5. Guidelines for health technology assessment in Thailand (second edition)--the development process.

   Chaikledkaew U, Kittrongsiri K. J Med Assoc Thai. 2014; 97(5) :54-59.
   
   

6. Knowledge, acceptance, and willingness to pay for human papilloma virus (HPV) vaccination among female parents in Thailand

   Kruiroongroj S, Chaikledkaew U, Thavorncharoensap M*. Asian Pacific Journal of Cancer Prevention 2014; 15(13): 5469-5474
   
   

7. Presentation of economic evaluation results.

   Chaikledkaew U*. Journal of the Medical Association of Thailand 2014; 97(5): s72-s80
   
   

8. Quality assessment of health economic evaluation.

   Chaikledkaew U, Kittrongsiri K. J Med Assoc Thai. 2014; 97(5) :S113-8.
   
   

9. Safety of Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Systematic Review

   Sangroongruangsri S, Chaikledkaew U*. Mahidol University Journal of Pharmaceutical Sciences 2014; 41 (3): 23-30.
   
   

2013

1. Advanced health biotechnologies in Thailand: Redefining policy directions

   Velasco R.P*, Chaikledkaew U, Myint CY, Khampang R, Tantivess S, Teerawattananon Y. Journal of Translational Medicine 2013; 11(1)
   
   

2. Efficacy of Varenicline and Nortriptyline in Smoking Cessation: Indirect Comparison of Randomized Controlled Trials

   Khairod P, Apichartkulchai S, Chaikledkaew U, Thavorncharoensap M* Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 31-39
   
   

3. Systematic Review of Economic Evaluation of Drug Treatments in Pulmonary Arterial Hypertension (PAH)

   Thongsri W, Chaikledkaew U*, Teerawattananon Y. Mahidol University Journal of Pharmaceutical Sciences 2013; 40(2): 45-50.
   
   

2012

1. Clinical Efficacy of Chronic Hepatitis B Treatment for Patients with HBeAg-Positive Indirect Comparison: Indirect Comparison Meta-Analysis

   Tantai N, Lerdkiattikorn P, Chaikledkaew U*, Tanwandee T, Weerayingyong P, Teerawattananon Y. Mahidol University Journal of Pharmaceutical Sciences 2012; 39(2): 37-40
   
   

2. Quality of Life among Stage III Colon Cancer Patients Receiving Oral and Intravenous Chemotherapy Reimens in Thailand.

   Lerdkiattikorn P, Tantai N, Chaikledkaew U*, Lausoontornsiri W, Khuhaprema T, Kingkaew P, Teerawattananon Y. Mahidol University Journal of Pharmaceutical Sciences 2012; 39(2): 50-52
   
   

3. Systematic Review of Economic Evaluation of The Surveillance Programs for Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B Patients.

   Sangmala P, Chaikledkaew U*, Tanwandee T. Mahidol University Journal of Pharmaceutical Sciences 2012; 39(1): 33-37.
   
   

4. Systematic Review of Economic Evaluation of Pharmacist Intervention Related to Adverse Drug Event Prevention among Patients with Hospitalization.

   Uaviseswong T, Chaikledkaew U*, Tragulpiankit P. Mahidol University Journal of Pharmaceutical Sciences 2012; 39(1): 38-43.
   
   

5. Systematic Review of Economic Evaluation of the First Line Treatment for Metastasis Renal Cell Carcinomo (mRCC).

   Chanatittarat C, Chaikledkaew U*. Mahidol University Journal of Pharmaceutical Sciences 2012; 39(3-4): 39-42.
   
   

2011

1. การเข้าถึงและปัจจัยที่มีผลต่อการเข้าถึงการผ่าตัดต้อ

   กัลยา ตีระวัฒนานนท์, รักมณี บุตรชน, ขวัญใจ วงศ์กิตติรักษ์, ชนิดา เลิศพิทักษ์พงศ์, ธีระ ศิริสมุด, อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์ วารสารวิชาการสาธารณสุข. 2011; 20:SI53-SI68
   
   

2. ความคุ้มค่าของการผ่าตัดต้อกระจกโดยใส่เลนส์แก้วตาเทียมชนิดนิ่มเปรียบเทียบกับชนิดแข็งในบริบทของประเทศไทย

   กัลยา ตีระวัฒนานนท์, ขวัญใจ วงศ์กิตติรักษ์, รักมณี บุตรชน, ปฤษพร กิ่งแก้ว,อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์ วารสารวิชาการสาธารณสุข 2554; 20(2): 235-250
   
   

3. ทบทวนการดำเนินการลดการบริโภคเครื่องดื่มแอลกอฮอล์ในประเทศไทย พ.ศ.2540-2550

   จอมขวัญ โยธาสมุทร, ศิตาพร ยังคง, ยศ ตีระวัฒนานนท์, มนทรัตม์ ถาวรเจริญทรัพย์, ศรีเพ็ญ ตันติเวสส, อุษา ฉายเกล็ดแก้ว, อดุลย์ โมฮารา, ชนิดา เลิศพิทักษ์พงศ์, อินทิรา ยมาภัย, วารสารวิชาการสาธารณสุข. 2011; 5(3): 307-316
   
   

2010

1. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

   Leelahavarong P,Chaikledkaew U*, Hongeng S, Kasemsup V, Lubell Y, Teerawattananon Y. BMC Health Services Research 2010; 10: Art. No. 209
   
   

2. Budget impact of the thalassemia management under the national health security scheme in Thailand

   Riewpaiboon A*, Bunyadharokul S, Chaikledkaew U, Torcharus K. Mahidol J Pharm. Sci 2010; 37(1-2): 28-39.
   
   

3. The economic costs of alcohol consumption in Thailand, 2006

   Thavorncharoensap M*, Teerawattananon Y, Yothasamut J, Lertpitakpong C, Thitiboonsuwan K, Neramitpitagkul P, Chaikledkaew U. BMC Public Health 2010; 10: 323
   
   

4. ปัจจัยที่มีผลต่อการเข้าถึงการผ่าตัดผ่านกล้องในประเทศไทย: ผลการวิเคราะห์ข้อมูลผู้ป่วยในระดับประเทศ ปี พ.ศ. 2548-2550

   วชิรานี วงศ์ก้อม, คัคนางค์ ไชรศิริ, อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์ วารสารมหาวิทยาลัยศรีนครินทรวิโรฒ (สาขาวิทยาศาสตร์และเทคโนโลยี) 2553; 2(Suppl.1): 95-105.
   
   

2009

1. Assessing enforcement of policy on limiting alcohol accessibility and alcohol purchasing. ;

   Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Thitiboonsuwan K, Yothasamut J, Chaikledkaew U. J Health Science 2009;18: 537-49.
   
   

2. Cost of productivity loss due to premature mortality related to alcohol drinking in Thailand.

   Lertpitakpong C, Thavorncharoensap M, Neramitpitagkul P,Chaikledkaew U, Teerawattananon Y. J Health Science 2009:18:3:322-332.
   
   

3. Economic impact on health care costs related to major diseases including HIV/AIDS due to alcohol drinking among Thai populations

   Neramitpitagkul P, Lertpitakpong C, Yothasamut J, Thavorncharoensap M, Chaikledkaew U*, Teerawattananon Y. Value Health 2009; 12(Sp.lss.2 Suppl.3): S97-S100.
   
   

4. Provider-initiated HIV/AIDS counseling and testing at healthcare facilities in Thailand: a cluster-randomisation trial

   Teerawattananon Y, Leelukkanaveera Y, Thavorncharoensap M, Hanvoravongchai P, Ingsrisawang L, Tantives S, Chaikledkaew U, Mohara A, Lertpiriyasuwat C, Pimsawan N Journal of development effectiveness 2009:1(4):450-469.
   
   

5. The current capacity and future development of economic evaluation for policy decision making: a survey among researchers and decision makers in Thailand

   Chaikledkaew U*, Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Tangcharoensathien V. Value Health 2009; 12(Sp.Iss.2 Suppl.3): S31-S35.
   
   

6. The Economic impact of alcohol consumption: A systematic review

   Thavorncharoensap M*, Teerawattananon Y, Yothasamut J, Lertpitakpong C, Chaikledkaew U. Subst Abuse Treat Prev Policy 2009; 4: 20
   
   

7. ต้นทุนทางเศรษฐศาสตร์ของการขาดงานและด้อยประสิทธิภาพการทำงานจากการบริโภคแอลกอฮอล์

   กรรณิการ์ ฐิติบุญสุวรรณ, มนทรัตม์ ถาวรเจริญทรัพย์, ชนิดา เลิศพิทักษ์พงษ์, จอมขวัญ โยธาสมุทร, อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์ วารสารวิจัยระบบสาธารณสุข 2552; 3(1): 102-112
   
   

2008

1. A determination of topics for health technology assessment in Thailand: making decision makers involved

   Lertpitakpong C, Chaikledkaew U, Thavorncharoensap M, Tantivess S, Praditsitthikorn N, Youngkogn S, Yothasamut J, Udomsuk K, Sinthitichai K, Teerawattananon Y J Med Assoc Thai 2008;91(Suppl 2):S100-9.
   
   

2. A drug cost model for injuries due to road traffic accidents

   Riewpaiboon A, Piyauthakit P, Srijariya W, Chaikledkaew U Pharmacy Practice. 2008; 6(1) Jan: 9-14.
   
   

3. Economic burden of road traffic injuries: A micro-costing approach

   Riewpaiboon A, Piyauthakit P, Chaikledkaew U Southeast Asia J Trop Med Public Health 2008; 39(6): 1139-1149.
   
   

4. Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals

   Chaikledkaew U*, Pongcharoensuk P, Chaiyakunapruk N, Ongphiphadhanakul B. Value Health 2008; 11(Suppl.1): S69-S74. Mar
   
   

5. Factors associated with healthcare costs and hospitalizations in patients with diabetes in Thai public hospitals.

   Chaikledkaew U, Pongcharoensuk P, Chaiyakunapruk, Ongphiphadhanakul B. Value Health 2008; 2 (Suppl 1): S69-S74.
   
   

6. Making health technology assessment information available for decision making: the development of a Thai database.

   Kapol N, Maitreemit P, Chalongsuk R, Amrumpai Y, Sribundit N, Thavorncharoensap M, Chaikledkaew U, Teerawattananon Y. J Med Assoc Thai 2008;91(Suppl 2):S8-10
   
   

7. Presentation of economic evaluation results

   Chaikledkaew U*, Teerawattananon Y. J Med Assoc Thai 2008; 91 Suppl 2: S66-73
   
   

8. System dynamic modeling: An alternative method for budgeting

   Srijariya W, Riewpaiboon A, Chaikledkaew U. Value Health 2008; 11(Suppl.1): S115-S123. Mar
   
   

9. การคัดเลือกหัวข้อสำหรับการประเมินเทคโนโลยีและนโยบายด้านสุขภาพในประเทศ: กรณีศึกษาการมีส่วนร่วมโดยผู้กำหนดนโยบาย

   ชนิดา เลิศพิทักษ์พงศ์, อุษา ฉายเกล็ดแก้ว, มนทรัตม์ ถาวรเจริญทรัพย์, ศรีเพ็ญ ตันติเวสส, นัยนา ประดิษฐ์สิทธิกร, ศิตาพร ยังคง, จอมขวัญ โยธาสมุทร, กาญจนาถ อุดมสุข, กงกช สินธิติชัย, ยศ ตีระวัฒนานนท์ วารสารวิชาการสาธารณสุข 2551;17(4)
   
   

2005

1. Factors associated with healthcare cost saving in patients with diabetes to the California Medicaid populations (Medi-Cal)

   Chaikledkaew U, Johnson KA Value Health 2005; 8 (3): 314
   
   

2. Factors associated with healthcare expenditures and hospitalizations in Thai patients with diabetes at four public hospitals.

   Chaikledkaew U, Pongcharoensuk P, Ongphiphadhanakul B, Chaiyakunapruk N. Mahidol J Pharm Sci 2005; 32(1-2): 1-6.
   
   

3. The cost-effectiveness of donepezil and rivastigmine in the treatment of Alzheime

   Pattanaprateep O, Phongcharoensuk P,Chaikledkaew U Value Health 2005; 8(3): 314
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ รศ.ดร.ภญ. อุษา ฉายเกล็ดแก้ว ได้แก่ อุษา ฉายเกล็ดแก้ว ; Chaikledkaew U ;